IPO GMP Rates Today 🔔 Check the latest IPO GMP rates and see which IPOs are gaining heat in the market. https://t.co/0evifP9aZT Don’t miss out—updates refreshed daily! 🔔 #IPOGMP #IPOGMPToday #IPO https://t.co/SAPsR3TFPk
An infographic published Dec 22, 2025 that summarizes the Gujarat Kidney & Super Speciality IPO (price band, lot size, allotment/listing dates) and explicitly calls out the Grey Market Premium (GMP) value — directly illustrating the ‘GMP today’ metric and helping readers gauge likely listing gains as mentioned in the tweet.
Source: The Financial Express
Research Brief
What our analysis found
IPO Grey Market Premium (GMP) trackers have become a staple of India's retail investing ecosystem, with platforms like Ipofly and LiveGMP claiming to refresh data every 5 minutes and offering heatmaps, AI scores, and trend charts to help investors gauge pre-listing demand. Mainstream outlets such as the Economic Times, Business Standard, and Mint now routinely publish GMP figures for individual IPOs, underscoring just how deeply embedded this unofficial metric has become in market culture. Academic studies analyzing 270–300 Indian IPOs have found Spearman correlation coefficients of 0.8–0.89 between GMP and actual listing-day returns, lending some empirical weight to the indicator.
However, the reliability of GMP data is increasingly being questioned. An Anand Rathi Wealth analysis cited by Business Standard found that among 19 recent mainboard IPOs, over 60% listed below their reported GMPs, and 26% listed at or below issue price — revealing a pattern of systematic overestimation. Community-driven analyses on platforms like Reddit have corroborated these findings, with one January–February 2026 sample showing GMP overestimated listing gains in 67% of cases. Journalistic investigations, including a deep-dive by India Today, have documented high-profile misfires such as Paytm and Lenskart, where GMP failed to predict listing outcomes.
Regulators are now paying attention. SEBI has signaled plans to introduce a regulated pre-IPO or "when-issued" trading platform designed to bring transparency to the opaque grey market. Coverage of this initiative first appeared in Business Standard in August 2025 and continued through early 2026, suggesting a potential structural shift that could reshape how pre-listing sentiment is measured and reported for Indian IPOs.
Fact Check
Evidence from both sides
Supporting Evidence
Live tracker ecosystem confirms daily/real-time GMP updates
Platforms like Ipofly and LiveGMP publish live GMP values with claimed refresh intervals of every 5 minutes, alongside heatmaps and trend charts that explicitly flag IPOs "gaining heat," directly supporting the tweet's description of frequently refreshed GMP rate tracking.
Mainstream media coverage validates widespread use
The Economic Times, Business Standard, and Mint regularly report GMP numbers for individual IPOs, confirming that GMP tracking is a recognized and widely consumed market practice among Indian retail investors.
Empirical research shows strong GMP-to-listing correlation
Academic studies analyzing approximately 270–300 Indian IPOs have reported Spearman correlation coefficients of 0.8–0.89 between pre-listing GMP and actual listing-day returns, providing statistical evidence that GMP can serve as a meaningful demand and sentiment indicator.
Multiple independent aggregators and apps exist
The presence of numerous GMP tracking platforms — including ipogmp.live, iposgmp.com, and dedicated mobile apps — demonstrates a robust ecosystem that supports the tweet's premise of accessible, regularly updated GMP data for retail investors.
Contradicting Evidence
GMP is unofficial and unregulated
GMP data is gathered from unregulated over-the-counter markets not overseen by SEBI, NSE, or BSE. Trackers themselves include prominent disclaimers warning that GMP figures "may vary from the actual listing price" and should not be treated as formal investment advice.
Majority of recent IPOs listed below their reported GMPs
An Anand Rathi Wealth analysis cited by Business Standard found that over 60% of 19 recent mainboard IPOs listed below their GMP-implied prices, and 26% listed at or below issue price, indicating GMP systematically overstates expected listing gains.
High-profile GMP misfires documented by journalists
India Today, LiveMint, and Business Standard have reported multiple cases — including Paytm and Lenskart — where GMP diverged materially from actual listing outcomes. These reports warn that GMP can be manipulated and amplified by social media hype rather than reflecting genuine institutional demand.
Community analyses confirm overestimation pattern
Independent post-listing analyses shared on Reddit found that GMP overestimated listing gains in roughly 67% of IPOs tracked in a January–February 2026 sample, corroborating industry concerns about the metric's reliability.
SEBI planning regulated alternative
SEBI has signaled its intent to create a regulated pre-IPO trading platform to replace the opaque grey market, a move first reported in August 2025, suggesting the regulator itself views the current GMP ecosystem as insufficiently transparent and potentially harmful to retail investors.
Report an Issue
Found something wrong with this article? Let us know and we'll look into it.